A 19-week Cognition Study of Levetiracetam in Children With Partial Onset Seizures
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
A 12-week Evaluation Period will be used to characterize potential cognitive and
neuropsychological effects of LEV (20 - 60 mg/kg/day), as adjunctive treatment in children 4
- 16 years old, inclusive, with refractory partial onset seizures when compared to adjunctive
treatment with placebo.